Sustained Momentum Reinforces Long-Term Objectives Group H1 2025 revenue of €344.0m, up 6.5% organically and 6.2% in totalStrong H1 across both brands – Axway up 8.9% to €160.8m and SBS up 5.0% to ...

In this valuable study, the authors provide a simple yet elegant approach to identifying therapeutic targets that synergize to prevent therapeutic resistance in ovarian cancer using cell lines, ...